LIVE VIEW · ALZNAlzamend Neuro, Inc.HealthcareALZN research Sign up to open the full interactive terminal, save boards, and get alerts
ALZN · Live chart
Loading live chart
ALZN · Smart-money composite
Not enough smart-money filings yet for a composite score.
ALZN · Recent signals
Q3-2026: Beat consensus by 70.5%, EPS $-0.58 vs $-1.9635 estimateMEDIUMLONGJul 29
Q4-2026: Beat consensus by 31.2%, EPS $-0.47 vs $-0.6834 estimateMEDIUMLONGJul 29
Beat consensus by 70.5%, EPS $-0.58 vs $-1.9635 estimateMEDIUMLONGJul 26
Beat consensus by 70.5% - EPS $-0.58 vs $-1.9635 estimateMEDIUMLONGJul 25
Beat consensus by 70.5% - EPS $-0.58 vs $-1.9635 estimateMEDIUMLONGJul 25
Beat consensus by 70.5% - EPS $-0.58 vs $-1.9635 estimateMEDIUMLONGJul 25
Q3-2025: Beat consensus by 85.0% - EPS $-0.3 vs $-1.9941 estimateMEDIUMLONGJun 19
Beat consensus by 70.5% - EPS $-0.58 vs $-1.9635 estimateMEDIUMLONGJun 19
ALZN · Institutional holders
No 13F holdings on file for ALZN.
Live alerts on ALZN
Live alerts on ALZNGet pinged the moment insiders, congress, or 13F funds move on ALZN.Sign up to unlock
Options positioning and dealer gamma
Options positioning and dealer gammaDealer gamma, call and put walls, and expiry pressure for ALZN.Sign up to unlock
Build your own board
Build your own boardEvery ticker, your own layout, saved boards, and alerts in one terminal.Sign up to unlock